What to expect when you take Xolair and Panthenol?

Do you take Xolair and Panthenol? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 11, 2019

7,438 reports have been studied.


Females aged 50 to 59 :

5,517 related reports were analyzed:

Most common symptoms:

Anaphylaxis
  • 7.12% for females aged 50 (±5) who take Xolair
Asthma
  • 23.08% for females aged 50 (±5) who take Xolair
Back pain
  • 5.21% for females aged 50 (±5) who take Panthenol
Bronchitis
  • 6.27% for females aged 50 (±5) who take Xolair
Chest pain
  • 10.39% for females aged 50 (±5) who take Xolair
  • 5.49% for females aged 50 (±5) who take Panthenol
Cough
  • 13.1% for females aged 50 (±5) who take Xolair
Diarrhea
  • 8.47% for females aged 50 (±5) who take Panthenol
Dizziness
  • 7.42% for females aged 50 (±5) who take Xolair
  • 6.24% for females aged 50 (±5) who take Panthenol
Drug ineffective
  • 6.59% for females aged 50 (±5) who take Panthenol
  • 6.01% for females aged 50 (±5) who take Xolair
Dyspnea
  • 18.4% for females aged 50 (±5) who take Xolair
  • 5.6% for females aged 50 (±5) who take Panthenol
Fall
  • 6.34% for females aged 50 (±5) who take Panthenol
Fatigue
  • 12.62% for females aged 50 (±5) who take Xolair
  • 10.31% for females aged 50 (±5) who take Panthenol
Fever
  • 5.32% for females aged 50 (±5) who take Panthenol
Headache
  • 10.02% for females aged 50 (±5) who take Xolair
  • 9.85% for females aged 50 (±5) who take Panthenol
Heart rate increased
  • 6.01% for females aged 50 (±5) who take Xolair
High blood pressure
  • 11.21% for females aged 50 (±5) who take Xolair
Hypersensitivity
  • 7.31% for females aged 50 (±5) who take Xolair
Insomnia
  • 5.42% for females aged 50 (±5) who take Panthenol
Itching
  • 6.12% for females aged 50 (±5) who take Xolair
Joint pain
  • 7.94% for females aged 50 (±5) who take Panthenol
  • 6.27% for females aged 50 (±5) who take Xolair
Malaise
  • 10.65% for females aged 50 (±5) who take Xolair
Nasopharyngitis
  • 10.17% for females aged 50 (±5) who take Xolair
Nausea
  • 10.6% for females aged 50 (±5) who take Panthenol
  • 5.49% for females aged 50 (±5) who take Xolair
Nausea and vomiting
  • 6.13% for females aged 50 (±5) who take Panthenol
Pain
  • 10.63% for females aged 50 (±5) who take Panthenol
Pain in extremity
  • 5.95% for females aged 50 (±5) who take Panthenol
Pneumonia
  • 8.46% for females aged 50 (±5) who take Xolair
Productive cough
  • 5.9% for females aged 50 (±5) who take Xolair
Rashes
  • 6.98% for females aged 50 (±5) who take Panthenol
  • 6.53% for females aged 50 (±5) who take Xolair
Sinusitis
  • 5.97% for females aged 50 (±5) who take Xolair
Stress and anxiety
  • 5.6% for females aged 50 (±5) who take Panthenol
  • 5.01% for females aged 50 (±5) who take Xolair
The flu
  • 6.05% for females aged 50 (±5) who take Xolair
Urticaria
  • 5.57% for females aged 50 (±5) who take Xolair
Weakness
  • 6.2% for females aged 50 (±5) who take Panthenol
  • 5.94% for females aged 50 (±5) who take Xolair
Wheezing
  • 10.61% for females aged 50 (±5) who take Xolair

Most common co-existing conditions:

Crohn's disease
  • 5.46% for females aged 50 (±5) who take Panthenol
Depression
  • 7.48% for females aged 50 (±5) who take Panthenol
Gastroesophageal reflux disease
  • 6.2% for females aged 50 (±5) who take Panthenol
High blood cholesterol
  • 7.37% for females aged 50 (±5) who take Panthenol
High blood pressure
  • 9.71% for females aged 50 (±5) who take Panthenol
Multiple sclerosis
  • 9.64% for females aged 50 (±5) who take Panthenol
Osteoporosis
  • 6.52% for females aged 50 (±5) who take Panthenol
Pain
  • 10.84% for females aged 50 (±5) who take Panthenol
Rheumatoid arthritis
  • 15.84% for females aged 50 (±5) who take Panthenol
Stress and anxiety
  • 5.88% for females aged 50 (±5) who take Panthenol
Vitamin supplementation
  • 5.32% for females aged 50 (±5) who take Panthenol
back to top

Males aged 50 to 59 :

1,921 related reports were analyzed:

Most common symptoms:

Asthma
  • 27.43% for males aged 50 (±5) who take Xolair
Body temperature decreased
  • 5.08% for males aged 50 (±5) who take Xolair
Chest pain
  • 10.86% for males aged 50 (±5) who take Xolair
Cough
  • 16.3% for males aged 50 (±5) who take Xolair
Diarrhea
  • 6.27% for males aged 50 (±5) who take Panthenol
Dizziness
  • 7.21% for males aged 50 (±5) who take Xolair
  • 6.02% for males aged 50 (±5) who take Panthenol
Drug ineffective
  • 6.68% for males aged 50 (±5) who take Xolair
Dyspnea
  • 21.28% for males aged 50 (±5) who take Xolair
  • 7.77% for males aged 50 (±5) who take Panthenol
Fall
  • 5.01% for males aged 50 (±5) who take Panthenol
Fatigue
  • 12.78% for males aged 50 (±5) who take Panthenol
  • 11.22% for males aged 50 (±5) who take Xolair
Fever
  • 5.61% for males aged 50 (±5) who take Xolair
Headache
  • 8.99% for males aged 50 (±5) who take Xolair
Heart rate increased
  • 8.01% for males aged 50 (±5) who take Xolair
High blood pressure
  • 18.79% for males aged 50 (±5) who take Xolair
Hypersensitivity
  • 5.25% for males aged 50 (±5) who take Xolair
Joint pain
  • 6.77% for males aged 50 (±5) who take Panthenol
Malaise
  • 8.19% for males aged 50 (±5) who take Xolair
Nasal congestion
  • 5.43% for males aged 50 (±5) who take Xolair
Nasopharyngitis
  • 15.05% for males aged 50 (±5) who take Xolair
Nausea
  • 5.64% for males aged 50 (±5) who take Panthenol
Pain
  • 7.52% for males aged 50 (±5) who take Panthenol
Pneumonia
  • 8.01% for males aged 50 (±5) who take Xolair
  • 5.39% for males aged 50 (±5) who take Panthenol
Productive cough
  • 8.73% for males aged 50 (±5) who take Xolair
Rashes
  • 5.7% for males aged 50 (±5) who take Xolair
  • 5.01% for males aged 50 (±5) who take Panthenol
Sinus congestion
  • 5.43% for males aged 50 (±5) who take Xolair
Sinusitis
  • 6.14% for males aged 50 (±5) who take Xolair
Sputum discolored
  • 5.25% for males aged 50 (±5) who take Xolair
Stress and anxiety
  • 5.51% for males aged 50 (±5) who take Panthenol
The flu
  • 8.46% for males aged 50 (±5) who take Xolair
Weakness
  • 6.77% for males aged 50 (±5) who take Panthenol
Weight decreased
  • 6.23% for males aged 50 (±5) who take Xolair
Weight increased
  • 6.23% for males aged 50 (±5) who take Xolair
Wheezing
  • 15.23% for males aged 50 (±5) who take Xolair

Most common co-existing conditions:

Crohn's disease
  • 6.02% for males aged 50 (±5) who take Panthenol
Depression
  • 6.27% for males aged 50 (±5) who take Panthenol
High blood cholesterol
  • 5.01% for males aged 50 (±5) who take Panthenol
High blood pressure
  • 9.27% for males aged 50 (±5) who take Panthenol
Multiple myeloma
  • 14.04% for males aged 50 (±5) who take Panthenol
Multiple sclerosis
  • 5.51% for males aged 50 (±5) who take Panthenol
Pain
  • 7.64% for males aged 50 (±5) who take Panthenol
Rheumatoid arthritis
  • 5.51% for males aged 50 (±5) who take Panthenol
Vitamin supplementation
  • 5.51% for males aged 50 (±5) who take Panthenol
back to top

Do you take Xolair and Panthenol:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Xolair

Xolair has active ingredients of omalizumab. It is often used in asthma. (latest outcomes from Xolair 37,555 users)

Panthenol

Panthenol has active ingredients of pantothenic acid (vitamin b5). (latest outcomes from Panthenol 539 users)

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!